3rd Quarter - Report

C2 GROUP, LLC for BIOTECHNOLOGY INDUSTRY ORGANIZATION

Firm
Client
Income
$75,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Therapeutic discovery tax credits (H.R. 3962, S. 1796); H.R. 3590; counter measure and orphan drug exemption from pharmaceutical excise tax; Implementation of Section 48D if the IRC, Implementation of Therapeutic Discovery Research Tax Credit.;H.R.5297, Small Business Jobs and Credit Act 2010; H.R.4213/S.3793 Tax Extenders Act of 2009; Small business capital gains incentives for biotech companies;AMT credits in lieu of bonus depreciation for biotech companies

LobbyistCovered position, as disclosed
G HUNTER BATES —
JOHN CLINE —
THOMAS CRAWFORD —
LESLEY ELLIOTT —
MICHAEL HANSON —
ROLAND NELSON LITTERST —
JEFFERIES MURRAY —
DAVID PATRICK ROBERTSON Leg. Aide & Leg. Correspondent, Sen. Rockefeller

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; SENATE

Bills named: S. 1796 (111th), H.R. 5297 (111th), H.R. 3962 (111th), H.R. 3590 (111th), S. 3793 (111th), H.R. 4213 (111th)

Copyright/Patent/Trademark CPT

Reform Patent laws to encourage innovation (S. 515, S. 610).

LobbyistCovered position, as disclosed
G HUNTER BATES —
JOHN CLINE —
THOMAS CRAWFORD —
LESLEY ELLIOTT —
MICHAEL HANSON —
ROLAND NELSON LITTERST —
JEFFERIES MURRAY —
DAVID PATRICK ROBERTSON Leg. Aide & Leg. Correspondent, Sen. Rockefeller

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Treasury, Dept of

Bills named: S. 610 (111th), S. 515 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.